title: [Current studies in myotonic dystrophy].
abstract: Myotonic dystrophy (DM) is a genetic, progressive, multisystemic disease with muscular disorder as its primary symptom. There are two types of DM (DM1 and DM2) caused by mutations in different genes, and in Japan, DM occurs with an incidence of approximately 1 in 20,000. The pathogenic mechanism underlying the disease is RNA toxicity caused by transcripts of aberrantly elongated CTG or CCTG repeats located in the 3' untranslated region or in the intron. The current treatments for DM is limited to symptomatic care. In this review, we will discuss several new therapeutic strategies based on recent studies of RNA toxicity.
authors.affiliation: Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo.
authors.forename: Yimeng
authors.initials: Y
authors.lastname: Zhao
authors.forename: Shoichi
authors.initials: S
authors.lastname: Ishiura
mesh_terms: D006801:Humans; D007438:Introns; D009154:Mutation; D009223:Myotonic Dystrophy / Q000175:diagnosis / Q000209:etiology* / Q000235:genetics / Q000628:therapy*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism; D012313:RNA / Q000378:metabolism
chemical_list: D012313:RNA; D017346:Protein Serine-Threonine Kinases